Literature DB >> 32151398

Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].

F I Mulder1, N van Es2, N Kraaijpoel2, M Di Nisio3, M Carrier4, A Duggal5, M Gaddh6, D Garcia7, M A Grosso5, A K Kakkar8, M F Mercuri5, S Middeldorp2, G Royle9, A Segers10, S Shivakumar11, P Verhamme12, T Wang13, J I Weitz14, G Zhang5, H R Büller2, G Raskob15.   

Abstract

Entities:  

Year:  2020        PMID： 32151398     DOI： 10.1016/j.thromres.2020.02.022

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  1 in total

1.  Efficacy and Safety of Edoxaban in Cancer-Associated Venous Thromboembolism: A Real World Retrospective Study.

Authors:  Elisa Grifoni; Andrea Baroncelli; Gabriele Pinto; Eleonora Cosentino; Irene Micheletti; Ira Signorini; Grazia Panigada; Giancarlo Landini; Luca Masotti
Journal:  TH Open       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.